Mactores Signs Strategic AWS Partnership to Accelerate Enterprise GenAI Adoption by 80%
Mactores has partnered with AWS through a Strategic Collaboration Agreement and achieved…
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…
